T

Serial Number 97550016
Registration 7174771
700

Registration Progress

Application Filed
Aug 16, 2022
Under Examination
Approved for Publication
Jul 11, 2023
Published for Opposition
Jul 11, 2023
Registered
Sep 26, 2023

Trademark Image

T

Basic Information

Serial Number
97550016
Registration Number
7174771
Filing Date
August 16, 2022
Registration Date
September 26, 2023
Published for Opposition
July 11, 2023
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Sep 26, 2023
Registration
Registered
Classes
005

Rights Holder

TerSera Therapeutics LLC

16
Address
Suite 500
520 Lake Cook Road
Deerfield, IL 60015

Ownership History

TerSera Therapeutics LLC

Original Applicant
16
Deerfield, IL

TerSera Therapeutics LLC

Owner at Publication
16
Deerfield, IL

TerSera Therapeutics LLC

Original Registrant
16
Deerfield, IL

Legal Representation

Attorney
Mitchell J. Weinstein

USPTO Deadlines

Next Deadline
1418 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-09-26)
Due Date
September 26, 2029
Grace Period Ends
March 26, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

11 events
Date Code Type Description Documents
Jan 15, 2025 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Sep 26, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Sep 26, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jul 11, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 11, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 21, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 3, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 3, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 7, 2022 MDSM E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Sep 6, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 19, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical and medicinal preparations for use in oncology; pharmaceutical and medicinal preparations for the treatment of pain, migraines, allergic reactions, gynecological diseases and disorders, prostate cancer, breast cancer, carcinoid syndrome and carcinoid syndrome diarrhea
First Use Anywhere: Mar 10, 2017
First Use in Commerce: Mar 20, 2017

Additional Information

Design Mark
The mark consists of a stylized capital letter "T" consisting of a slanted horizontal bar with two shorter parallel bars below it and each bar is separated by a small amount of negative space.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005